Effect of branched-chain amino acids on muscle atrophy in cancer cachexia

Helen L. Eley, Steve T. Russell, Michael J. Tisdale*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

In the present study, the BCAAs (branched-chain amino acids) leucine and valine caused a significant suppression in the loss of body weight in mice bearing a cachexia-inducing tumour (MAC16), producing a significant increase in skeletal muscle wet weight, through an increase in protein synthesis and a decrease in degradation. Leucine attenuated the increased phosphorylation of PKR (double-stranded-RNA-dependent protein kinase) and eIF2α (eukaryotic initiation factor 2α) in skeletal muscle of mice bearing the MAC16 tumour, due to an increased expression of PP1 (protein phosphatase 1). Weight loss in mice bearing the MAC16 tumour was associated with an increased amount of eIF4E bound to its binding protein 4E-BP1 (eIF4E-binding protein 1), and a progressive decrease in the active eIF4G-eIF4E complex due to hypophosphorylation of 4E-BP1. This may be due to a reduction in the phosphorylation of mTOR (mammalian target of rapamycin), which may also be responsible for the decreased phosphorylation of p70S6k (70 kDa ribosomal S6 kinase). There was also a 5-fold increase in the phosphorylation of eEF2 (eukaryotic elongation factor 2), which would also decrease protein synthesis through a decrease in translation elongation. Treatment with leucine increased phosphorylation of mTOR and p70S6k, caused hyperphosphorylation of 4E-BP1, reduced the amount of 4E-BP1 associated with eIF4E and caused an increase in the eIF4G-eIF4E complex, together with a reduction in phosphorylation of eEF2. These changes would be expected to increase protein synthesis, whereas a reduction in the activation of PKR would be expected to attenuate the increased protein degradation. © The Authors.

Original languageEnglish
Pages (from-to)113-120
Number of pages8
JournalBiochemical Journal
Volume407
Issue number1
DOIs
Publication statusPublished - 10 Jul 2007

Fingerprint

Branched Chain Amino Acids
Cachexia
Phosphorylation
Muscular Atrophy
Muscle
Bearings (structural)
Peptide Elongation Factor 2
Leucine
70-kDa Ribosomal Protein S6 Kinases
Tumors
Neoplasms
Sirolimus
Carrier Proteins
Skeletal Muscle
Proteins
Eukaryotic Initiation Factor-2
eIF-2 Kinase
Ribosomal Protein S6 Kinases
Protein Phosphatase 1
Degradation

Keywords

  • branched-chain amino acid (BCAA)
  • cachexia
  • double-stranded-RNA-dependent protein kinase (PKR)
  • eukaryotic elongation factor 2 (eEF2)
  • eukaryotic-initiation factor 4E (eIF4E)
  • eukaryotic-initiation factor 4E-binding protein 1 (4E-BP1)
  • leucine

Cite this

Eley, Helen L. ; Russell, Steve T. ; Tisdale, Michael J. / Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. In: Biochemical Journal. 2007 ; Vol. 407, No. 1. pp. 113-120.
@article{1be4dd91f19e43d5b56629c327b535f1,
title = "Effect of branched-chain amino acids on muscle atrophy in cancer cachexia",
abstract = "In the present study, the BCAAs (branched-chain amino acids) leucine and valine caused a significant suppression in the loss of body weight in mice bearing a cachexia-inducing tumour (MAC16), producing a significant increase in skeletal muscle wet weight, through an increase in protein synthesis and a decrease in degradation. Leucine attenuated the increased phosphorylation of PKR (double-stranded-RNA-dependent protein kinase) and eIF2α (eukaryotic initiation factor 2α) in skeletal muscle of mice bearing the MAC16 tumour, due to an increased expression of PP1 (protein phosphatase 1). Weight loss in mice bearing the MAC16 tumour was associated with an increased amount of eIF4E bound to its binding protein 4E-BP1 (eIF4E-binding protein 1), and a progressive decrease in the active eIF4G-eIF4E complex due to hypophosphorylation of 4E-BP1. This may be due to a reduction in the phosphorylation of mTOR (mammalian target of rapamycin), which may also be responsible for the decreased phosphorylation of p70S6k (70 kDa ribosomal S6 kinase). There was also a 5-fold increase in the phosphorylation of eEF2 (eukaryotic elongation factor 2), which would also decrease protein synthesis through a decrease in translation elongation. Treatment with leucine increased phosphorylation of mTOR and p70S6k, caused hyperphosphorylation of 4E-BP1, reduced the amount of 4E-BP1 associated with eIF4E and caused an increase in the eIF4G-eIF4E complex, together with a reduction in phosphorylation of eEF2. These changes would be expected to increase protein synthesis, whereas a reduction in the activation of PKR would be expected to attenuate the increased protein degradation. {\circledC} The Authors.",
keywords = "branched-chain amino acid (BCAA), cachexia, double-stranded-RNA-dependent protein kinase (PKR), eukaryotic elongation factor 2 (eEF2), eukaryotic-initiation factor 4E (eIF4E), eukaryotic-initiation factor 4E-binding protein 1 (4E-BP1), leucine",
author = "Eley, {Helen L.} and Russell, {Steve T.} and Tisdale, {Michael J.}",
year = "2007",
month = "7",
day = "10",
doi = "10.1042/BJ20070651",
language = "English",
volume = "407",
pages = "113--120",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. / Eley, Helen L.; Russell, Steve T.; Tisdale, Michael J.

In: Biochemical Journal, Vol. 407, No. 1, 10.07.2007, p. 113-120.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of branched-chain amino acids on muscle atrophy in cancer cachexia

AU - Eley, Helen L.

AU - Russell, Steve T.

AU - Tisdale, Michael J.

PY - 2007/7/10

Y1 - 2007/7/10

N2 - In the present study, the BCAAs (branched-chain amino acids) leucine and valine caused a significant suppression in the loss of body weight in mice bearing a cachexia-inducing tumour (MAC16), producing a significant increase in skeletal muscle wet weight, through an increase in protein synthesis and a decrease in degradation. Leucine attenuated the increased phosphorylation of PKR (double-stranded-RNA-dependent protein kinase) and eIF2α (eukaryotic initiation factor 2α) in skeletal muscle of mice bearing the MAC16 tumour, due to an increased expression of PP1 (protein phosphatase 1). Weight loss in mice bearing the MAC16 tumour was associated with an increased amount of eIF4E bound to its binding protein 4E-BP1 (eIF4E-binding protein 1), and a progressive decrease in the active eIF4G-eIF4E complex due to hypophosphorylation of 4E-BP1. This may be due to a reduction in the phosphorylation of mTOR (mammalian target of rapamycin), which may also be responsible for the decreased phosphorylation of p70S6k (70 kDa ribosomal S6 kinase). There was also a 5-fold increase in the phosphorylation of eEF2 (eukaryotic elongation factor 2), which would also decrease protein synthesis through a decrease in translation elongation. Treatment with leucine increased phosphorylation of mTOR and p70S6k, caused hyperphosphorylation of 4E-BP1, reduced the amount of 4E-BP1 associated with eIF4E and caused an increase in the eIF4G-eIF4E complex, together with a reduction in phosphorylation of eEF2. These changes would be expected to increase protein synthesis, whereas a reduction in the activation of PKR would be expected to attenuate the increased protein degradation. © The Authors.

AB - In the present study, the BCAAs (branched-chain amino acids) leucine and valine caused a significant suppression in the loss of body weight in mice bearing a cachexia-inducing tumour (MAC16), producing a significant increase in skeletal muscle wet weight, through an increase in protein synthesis and a decrease in degradation. Leucine attenuated the increased phosphorylation of PKR (double-stranded-RNA-dependent protein kinase) and eIF2α (eukaryotic initiation factor 2α) in skeletal muscle of mice bearing the MAC16 tumour, due to an increased expression of PP1 (protein phosphatase 1). Weight loss in mice bearing the MAC16 tumour was associated with an increased amount of eIF4E bound to its binding protein 4E-BP1 (eIF4E-binding protein 1), and a progressive decrease in the active eIF4G-eIF4E complex due to hypophosphorylation of 4E-BP1. This may be due to a reduction in the phosphorylation of mTOR (mammalian target of rapamycin), which may also be responsible for the decreased phosphorylation of p70S6k (70 kDa ribosomal S6 kinase). There was also a 5-fold increase in the phosphorylation of eEF2 (eukaryotic elongation factor 2), which would also decrease protein synthesis through a decrease in translation elongation. Treatment with leucine increased phosphorylation of mTOR and p70S6k, caused hyperphosphorylation of 4E-BP1, reduced the amount of 4E-BP1 associated with eIF4E and caused an increase in the eIF4G-eIF4E complex, together with a reduction in phosphorylation of eEF2. These changes would be expected to increase protein synthesis, whereas a reduction in the activation of PKR would be expected to attenuate the increased protein degradation. © The Authors.

KW - branched-chain amino acid (BCAA)

KW - cachexia

KW - double-stranded-RNA-dependent protein kinase (PKR)

KW - eukaryotic elongation factor 2 (eEF2)

KW - eukaryotic-initiation factor 4E (eIF4E)

KW - eukaryotic-initiation factor 4E-binding protein 1 (4E-BP1)

KW - leucine

UR - http://www.scopus.com/inward/record.url?scp=35148822373&partnerID=8YFLogxK

UR - http://www.biochemj.org/bj/407/bj4070113.htm

U2 - 10.1042/BJ20070651

DO - 10.1042/BJ20070651

M3 - Article

C2 - 17623010

VL - 407

SP - 113

EP - 120

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -